Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PON2 and PPARG polymorphisms as biomarkers of risk for coronary heart disease.

Biomarkers in medicine - 1 Mar 2018

González-Castro Thelma Beatriz, Tovilla-Zárate Carlos Alfonso, Juárez-Rojop Isela Esther, Hernández-Díaz Yazmín, López-Narváez María Lilia, Rodríguez-Pérez Candelario, González-Hernández Yahaira Karina, Ramos-Méndez Miguel Ángel

Abstract excerpt

AIM: Investigate the correlation between paraoxonase 2 (PON2) Ser311Cys polymorphism as well as the peroxisome proliferator-activated receptor gamma (PPARG) His477His polymorphism and the susceptibility to development of coronary heart diseases (CHD) through a meta-analysis. METHODS: Odds ratio and the corresponding 95% CI were used to assess the results. We included 7476 CHD patients and 8504 healthy controls....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aryldialkylphosphatase
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Coronary Disease

Share to Meta-Analysis as Topic

Share to Odds Ratio

Share to Polymorphism, Single Nucleotide

Share to PPAR gamma

Share to Risk Factors

Source

Identifiers

PMID: 29441810
DOI: 10.2217/bmm-2017-0227

Genes

PON2
PPARG

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PON2 and PPARG polymorphisms as biomarkers of risk for coronary heart disease.PMID 29441810Read ↗

Association Between Paraoxonase 2 Ser311Cys Polymorphism and Coronary Heart Disease Risk: A Meta-Analysis.Semantic proximity Read ↗

Association between peroxisome proliferator-activated receptor-alpha, delta, and gamma polymorphisms and risk of coronary heart disease: A case-control study and meta-analysis.Semantic proximity Read ↗

Significant association between paraoxonase 1 rs662 polymorphism and coronary heart disease : A meta-analysis in the Chinese population.Semantic proximity Read ↗

Four genetic polymorphisms of paraoxonase gene and risk of coronary heart disease: a meta-analysis based on 88 case-control studies.Semantic proximity Read ↗

The meta-analysis of the association of PPARG P12A, C161T polymorphism and coronary heart disease.Semantic proximity Read ↗

Functional Variant of C-689T in the Peroxisome Proliferator-Activated Receptor-γ2 Promoter is Associated with Coronary Heart Disease in Chinese Nondiabetic Han People.Semantic proximity Read ↗

DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease.Semantic proximity Read ↗

Genetic associations with coronary heart disease: meta-analyses of 12 candidate genetic variants.Semantic proximity Read ↗

The effect of PPARG gene polymorphisms on the risk of coronary heart disease: a meta-analysis.Semantic proximity Read ↗

Peroxisome Proliferator‐Activated Receptor Gamma Polymorphisms and Coronary Heart DiseaseSemantic proximity Read ↗

The risk of coronary artery disease in population of Taiwan is associated with Cys-Ser 311 polymorphism of human paraoxonase (PON)-2 gene.Semantic proximity Read ↗

PPARγ Gene Polymorphisms, Metabolic Disorders, and Coronary Artery DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.